Nitric oxide synhase inhibitors effects on acute and chronic L-dopa-induced dyskinesias in the 6-OHDA rat model of Parkinson's disease

被引：0
作者：
Padovan-Neto, F. E.
Echeverry, M. B.
Tumas, V.
Del Bel, E. A.
机构：
来源：
MOVEMENT DISORDERS | 2009年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S247 / S247
页数：1
相关论文
共 50 条
[41]   STRIATAL mRNA EXPRESSION PATTERNS UNDERLYING PEAK DOSE L-DOPA-INDUCED DYSKINESIA IN THE 6-OHDA HEMIPARKINSONIAN RAT [J].
Smith, L. M. ;
Parr-Brownlie, L. C. ;
Duncan, E. J. ;
Black, M. A. ;
Gemmell, N. J. ;
Dearden, P. K. ;
Reynolds, J. N. J. .
NEUROSCIENCE, 2016, 324 :238-251
[42]   Immunomodulatory Drugs Alleviate L-Dopa-Induced Dyskinesia in a Rat Model of Parkinson's Disease [J].
Boi, Laura ;
Pisanu, Augusta ;
Greig, Nigel H. ;
Scerba, Michael T. ;
Tweedie, David ;
Mulas, Giovanna ;
Fenu, Sandro ;
Carboni, Ezio ;
Spiga, Saturnino ;
Carta, Anna R. .
MOVEMENT DISORDERS, 2019, 34 (12) :1818-1830
[43]   Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson's disease: a dose-finding study [J].
Svenningsson, Per ;
Rosenblad, Carl ;
Arvidsson, Karolina af Edholm ;
Wictorin, Klas ;
Keywood, Charlotte ;
Shankar, Bavani ;
Lowe, David A. ;
Bjorklund, Anders ;
Widner, Hakan .
BRAIN, 2015, 138 :963-973
[44]   Neuroprotective effects of L-Dopa-modified zinc oxide nanoparticles on the rat model of 6-OHDA-ınduced Parkinson's disease [J].
Yeni, Yesim ;
Genc, Sidika ;
Ertugrul, Muhammed Sait ;
Nadaroglu, Hayrunnisa ;
Gezer, Arzu ;
Mendil, Ali Sefa ;
Hacimuftuoglu, Ahmet .
SCIENTIFIC REPORTS, 2024, 14 (01)
[45]   Comparison of motor fluctuations and L-dopa-induced dyskinesias in patients with familial and sporadic Parkinson's disease [J].
Papapetropoulos, S ;
Argyriou, AA ;
Ellul, J ;
Chroni, E .
EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 (02) :115-119
[46]   Angiotensin-converting enzyme inhibition prevents l-dopa-induced dyskinesia in a 6-ohda-induced mouse model of Parkinson's disease [J].
Park, Hye-Yeon ;
Lee, Ga Seul ;
Go, Jun ;
Ryu, Young-Kyoung ;
Lee, Chul-Ho ;
Moon, Jeong Hee ;
Kim, Kyoung-Shim .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2024, 973
[47]   Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease [J].
Rascol, O ;
Arnulf, I ;
Paul, HPS ;
Brefel-Courbon, C ;
Vidailhet, M ;
Thalamas, C ;
Bonnet, AM ;
Descombes, S ;
Bejjani, B ;
Fabre, N ;
Montastruc, JL ;
Agid, Y .
MOVEMENT DISORDERS, 2001, 16 (04) :708-713
[48]   Selegiline and L-DOPA modulate the number of newborn neurons in the olfactory bulb in an acute 6-OHDA mouse model of Parkinson's disease [J].
Chiu, W. H. ;
Carlsson, T. ;
Depboylu, C. ;
Oertel, W. H. ;
Hoeglinger, G. U. ;
Ries, V. .
MOVEMENT DISORDERS, 2013, 28 :S379-S379
[49]   Behavioral effects of zonisamide on L-DOPA-induced dyskinesia in Parkinson's disease model mice [J].
Sano, Hiromi ;
Nambu, Atsushi .
FRONTIERS IN AGING NEUROSCIENCE, 2023, 15
[50]   Priming for L-dopa-induced dyskinesia is inhibited by blockade of calcium-permeable AMPA receptors in the 6-OHDA-lesioned rat model of Parkinson's disease [J].
Kobylecki, C. ;
Crossman, A. R. ;
Ravenscroft, P. .
MOVEMENT DISORDERS, 2009, 24 :S354-S355
12345